Revaccination with Fendrix® or HBVaxPro® results in better response rates than does revaccination with three doses of Engerix-B® in previous non-responders

Vaccine

Volumn 30, Issue 48, 2012, Pages 6734-6737

  Hoebe, Christian J P A ^a,b   Vermeiren, Angelique P A ^a   Dukers Muijrers, Nicole H T M ^a,b  

^a Department of Sexual Health   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hepatitis B antibodies; Hepatitis B vaccines; Revaccination; Secondary immunisation

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; DRUG RESPONSE; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVACCINATION; SINGLE DRUG DOSE;

ADULT; COHORT STUDIES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84868195835     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.08.074     Document Type: Article

References (20)

1. Goldstein S.T., Zhou F., Hadler S.C., Bell B.P., Mast E.E., Margolis H.S. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005, 34:1329-1339.
2. Centers for Disease Control and Prevention Recommended adult immunization schedule. MMWR 2012, 61(4).
3. Jack A.D., Hall A.J., Maine N., Mendy M., Whittle H.C. What level of hepatitis B antibody is protective?. J Infect Dis 1999, 179:489-492.
4. Yu A.S., Cheung R.C., Keeffe E.B. Hepatitis B Vaccines. Infect Dis Clin North Am 2006, 20:27-45.
5. Cardell K., åkerlind B., Sällberg M., Frydén A. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous non-responders to hepatitis B vaccine. J Infect Dis 2008, 198:299-304.
6. Heininger U., Bachtiar N.S., Bahri P., Dana A., Dodoo A., Gidudu J., et al. The concept of vaccination failure. Vaccine 2012, 30:1265-1268.
7. Höhler T., Reuss E., Evers N., Dietrich E., Rittner C., Freitag C.M., et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet 2002, 360:991-995.
8. Roukens A.H., Hepatitis Visser L.G. B vaccination strategy in vaccine low- and non-responders. Human Vaccines 2011, 7:654-657.
9. Beran J. Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients. Expert Opin Biol Ther 2008, 8:235-247.
10. Jacques P., Moens G., Desombere I., Dewijngaert J., Leroux-Roels G., Wettendorff M., et al. The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population. Vaccine 2002, 20:3644-3649.
11. Hadler S.C., Francis D.P., Maynard J.E., Thompson S.E., Judson F.N., Echenberg D.F., et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986, 315:209-214.
12. Rendi-Wagner P., Shouval D., Genton B., Lurie Y., Rümke H., Boland G., et al. Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine. Vaccine 2006, 24:2781-2789.
13. Goldwater P.N. Randomized, comparative trial of 20 micrograms vs 40 micrograms Engerix B vaccine in hepatitis B vaccine non-responders. Vaccine 1997, 15:353-356.
14. Lin C., Zhu J., Zheng Y., Chen Y., Wu Z., Chong Y., et al. Effect of GM-CSF in combination with hepatitis B vaccine on revacination of healthy adult non-responders. J Infect 2010, 60:264-270.
15. Rottinghaus S.T., Poland G.A., Jacobson R.M., Barr L.J., Hepatitis Roy M.J. B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination. Vaccine 2003, 21:4604-4608.
16. Zuckerman J.N., Zuckerman A.J., Symington I., Du W., Williams A., Dickson B., et al. Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccines. Hepatology 2001, 34:798-802.
17. Struve J., Aronsson B., Frenning B., Forsgren M., Weiland O. Seroconversion after additional vaccine doses to non-responders to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine. Scand J Infect Dis 1994, 26:468-470.
18. Stoffel M., Lievens M., Dieussaert I., Martin I., Andre F. Immunogenicity of Twinrix in older adults: a critical analysis. Expert Rev Vaccines 2003, 2(1):9-14.
19. Van der Wielen M., Van Damme P., Chlibek R., Smetana J., von Sonnenburg F. Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors. Vaccine 2006, 24:5509-5515.
20. Wolters B., Junge U., Dziuba S., Roggendorf M. Immunogenicity of combined hepatitis A and B vaccine in elderly persons. Vaccine 2003, 21:3623-3628.